Nabiximols is used for cure of spasticity associated with MS when other therapies haven't worked, and when an Preliminary demo demonstrates "significant enhancement".[four] Trials for FDA approval in the US are underway.The extraction and reporting of information outcomes was carried out at a significant degree and didn't require an in-depth analys